| Pjl Management, Inc | |
|
200 Congress Park Dr Ste 210 Delray Beach FL 33445-4688 | |
| (561) 279-0991 | |
| (561) 279-0539 |
| Full Name | Pjl Management, Inc |
|---|---|
| Speciality | Clinic/Center |
| Location | 200 Congress Park Dr Ste 210, Delray Beach, Florida |
| Authorized Official Name and Position | Lorelli Sharon Sitahal (SECRETARY) |
| Authorized Official Contact | 5612790991 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Pjl Management, Inc 200 Congress Park Dr Ste 210 Delray Beach FL 33445-4688 Ph: (561) 279-0991 | Pjl Management, Inc 200 Congress Park Dr Ste 210 Delray Beach FL 33445-4688 Ph: (561) 279-0991 |
| NPI Number | 1063580140 |
|---|---|
| Provider Enumeration Date | 11/30/2006 |
| Last Update Date | 01/11/2018 |
| Medicare PECOS PAC ID | 7214834597 |
|---|---|
| Medicare Enrollment ID | O20031215000938 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.
A new study funded by the NIH says that increasing rates of the chronic lung condition called emphysema are linked to breathing polluted air over a long period. The progression of emphysema, a condition more commonly linked to smoking, is now also being attributed to polluted air. Air pollution is already known to be associated with lung and cardiovascular disease.
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063580140 | NPI | - | NPPES |
| 267866700 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261Q00000X | Clinic/center | (Florida) | Primary |
| Provider Name | Pierre A Dorsainvil |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1720013998 PECOS PAC ID: 3476450750 Enrollment ID: I20031216000078 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.
A new study funded by the NIH says that increasing rates of the chronic lung condition called emphysema are linked to breathing polluted air over a long period. The progression of emphysema, a condition more commonly linked to smoking, is now also being attributed to polluted air. Air pollution is already known to be associated with lung and cardiovascular disease.
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.
› Verified 2 days ago
| Provider Name | Tina M Mabe |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1497935803 PECOS PAC ID: 2062592512 Enrollment ID: I20080109000546 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.
A new study funded by the NIH says that increasing rates of the chronic lung condition called emphysema are linked to breathing polluted air over a long period. The progression of emphysema, a condition more commonly linked to smoking, is now also being attributed to polluted air. Air pollution is already known to be associated with lung and cardiovascular disease.
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.
› Verified 2 days ago
| Provider Name | Louidor Alliance |
|---|---|
| Provider Type | Practitioner - General Practice |
| Provider Identifiers | NPI Number: 1043513930 PECOS PAC ID: 2961673983 Enrollment ID: I20110923000441 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.
A new study funded by the NIH says that increasing rates of the chronic lung condition called emphysema are linked to breathing polluted air over a long period. The progression of emphysema, a condition more commonly linked to smoking, is now also being attributed to polluted air. Air pollution is already known to be associated with lung and cardiovascular disease.
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.
› Verified 2 days ago
| Provider Name | Susen Annette Carter-nealy |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1992178842 PECOS PAC ID: 1759685548 Enrollment ID: I20160216000518 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.
A new study funded by the NIH says that increasing rates of the chronic lung condition called emphysema are linked to breathing polluted air over a long period. The progression of emphysema, a condition more commonly linked to smoking, is now also being attributed to polluted air. Air pollution is already known to be associated with lung and cardiovascular disease.
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.
› Verified 2 days ago
| Provider Name | Noe Joseph |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1942767918 PECOS PAC ID: 6002248879 Enrollment ID: I20191115001756 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.
A new study funded by the NIH says that increasing rates of the chronic lung condition called emphysema are linked to breathing polluted air over a long period. The progression of emphysema, a condition more commonly linked to smoking, is now also being attributed to polluted air. Air pollution is already known to be associated with lung and cardiovascular disease.
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.
› Verified 2 days ago
| Provider Name | Wislande Gilles |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1194341545 PECOS PAC ID: 2961819032 Enrollment ID: I20210408000252 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.
A new study funded by the NIH says that increasing rates of the chronic lung condition called emphysema are linked to breathing polluted air over a long period. The progression of emphysema, a condition more commonly linked to smoking, is now also being attributed to polluted air. Air pollution is already known to be associated with lung and cardiovascular disease.
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.
› Verified 2 days ago
| Provider Name | Ruth Estriplet |
|---|---|
| Provider Type | Practitioner - Nurse Practitioner |
| Provider Identifiers | NPI Number: 1790344497 PECOS PAC ID: 0749663342 Enrollment ID: I20221017000539 |
News Archive
Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.
A new study funded by the NIH says that increasing rates of the chronic lung condition called emphysema are linked to breathing polluted air over a long period. The progression of emphysema, a condition more commonly linked to smoking, is now also being attributed to polluted air. Air pollution is already known to be associated with lung and cardiovascular disease.
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.
› Verified 2 days ago
News Archive
Arena Pharmaceuticals, Inc. announced today that the European Medicines Agency (EMA) has accepted the filing of a Marketing Authorization Application (MAA) for lorcaserin, an investigational drug candidate intended for weight control, including weight loss and maintenance of weight loss, in patients who are obese (BMI >30) or patients who are overweight (BMI >27) and have at least one weight-related co-morbid condition.
A new study funded by the NIH says that increasing rates of the chronic lung condition called emphysema are linked to breathing polluted air over a long period. The progression of emphysema, a condition more commonly linked to smoking, is now also being attributed to polluted air. Air pollution is already known to be associated with lung and cardiovascular disease.
A new study by researchers at the University of Colorado Denver and Massachusetts General Hospital (MGH) shows vitamin D plays a vital role in reducing the risk of death associated with older age. The research, just published in the Journal of the American Geriatrics Society, evaluated the association between vitamin D levels in the blood and the death rates of those 65 and older. The study found that older adults with insufficient levels of vitamin D die from heart disease at greater rates that those with adequate levels of the vitamin.
VG Life Sciences, (VGLS), a biotechnology company developing therapies for autoimmune and infectious diseases, today announced the U.S. Patent and Trademark Office (USPTO) has issued U.S. Patent No. 8906846, covering a method of treating inflammatory bowel disease (IBD) through the administration of a CLIP-inducing agent.
› Verified 2 days ago
Delray Physician Care Center Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 2280 W Atlantic Ave, Delray Beach, FL 33445 Phone: 561-278-3134 Fax: 561-278-3922 | |
Amicus Medical Center Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5130 Linton Blvd, Delray Beach, FL 33484 Phone: 561-725-5630 Fax: 561-496-0541 | |
Cogent Healthcare Of Pensacola Llc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 5352 Linton Blvd, Delray Beach, FL 33484 Phone: 561-498-4440 | |
Elena Yamaguchi Md Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 13550 Jog Rd, Suite 202a, Delray Beach, FL 33446 Phone: 561-495-9289 Fax: 561-495-9293 | |
Cohen Medical Associates Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 15300 Jog Rd, Suite 205, Delray Beach, FL 33446 Phone: 561-496-7200 Fax: 561-496-7289 | |
Bhanmatie Singh Do Pa Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 5341 W Atlantic Ave Ste 300c, Delray Beach, FL 33484 Phone: 561-501-4992 Fax: 844-274-9201 | |
Mark Paris Md Inc. Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 100 E Linton Blvd Ste 503a, Delray Beach, FL 33483 Phone: 561-265-4969 Fax: 561-265-4392 |